Published in

American Society for Microbiology, Journal of Virology, 1(97), 2023

DOI: 10.1128/jvi.01638-22

Links

Tools

Export citation

Search in Google Scholar

Characterization of a Novel CD4 Mimetic Compound YIR-821 against HIV-1 Clinical Isolates

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Orange circle
Published version: archiving restricted
Data provided by SHERPA/RoMEO

Abstract

Small CD4-mimetic compound (CD4mc) interacts with the Phe43 cavity and triggers conformational changes, enhancing antibody-mediated neutralization and antibody-dependent cellular cytotoxicity (ADCC). Here, we evaluated the effect of YIR-821, a novel CD4mc, against clinical isolates, including both subtype B and non-B subtype viruses.